This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shandong Luye Pharmaceutical Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Aiping Wang: Innovator in Pharmaceutical Compositions
Introduction
Aiping Wang is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating Parkinson's disease. His innovative work has led to the filing of a patent that addresses critical aspects of drug formulation.
Latest Patents
Aiping Wang holds a patent for "Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative." This patent describes a composition that includes rotigotine or a pharmaceutically acceptable salt, at least one poly(lactide-co-glycolide) (PLGA), and at least one fatty acid. The composition is designed to have a significantly reduced burst release effect, which is crucial for effective treatment. The patent also outlines a method for treating Parkinson's disease by administering an effective amount of this composition to patients in need.
Career Highlights
Aiping Wang is associated with Shandong Luye Pharmaceutical Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation and delivery systems has positioned him as a key player in the industry.
Collaborations
Aiping Wang collaborates with talented colleagues, including Youxin Li and Wanhui Liu, who contribute to the research and development efforts at their company. These collaborations enhance the potential for groundbreaking advancements in pharmaceutical sciences.
Conclusion
Aiping Wang's contributions to the field of pharmaceuticals, particularly through his patent on rotigotine compositions, highlight his role as an innovator. His work not only advances medical treatments but also showcases the importance of collaboration in achieving significant breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile